Ryan Specialty Annual report pursuant to Section 13 and 15(d)

Derivatives (Tables)

12 Months Ended

Dec. 31, 2023

The location and gains (losses) on non-hedging and hedging derivatives are reported on the Consolidated Statements of Income as follows:


		Year Ended December 31,
	Income Statement Caption	2023			2022
Change in the fair value of the Deal-Contingent Forward	General and administrative	$	(852	)	$	—
Total impact of derivatives not designated as hedging instruments		$	(852	)	$	—

Interest rate cap premium amortization	Interest expense, net	$	(6,955	)	$	(4,636	)
Amounts reclassified out of other comprehensive income related to the interest rate cap	Interest expense, net		22,900			2,174
Total impact of derivatives designated as hedging instruments		$	15,945		$	(2,462	)

The location and fair value of non-hedging and hedging derivatives are reported on the Consolidated Balance sheets as follows:


		As of December 31,
	Balance Sheet Caption	2023		2022
Derivatives not designated as hedging instruments
Deal-Contingent Forward	Accounts payable and accrued liabilities	$	852	$	—
Derivatives designated as hedging instruments
Interest rate cap	Other non-current assets	$	29,667	$	45,860